LIM
FLACU

Longfellow Investment Management’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Longfellow Investment Management’s Portfolio FLACU Stock Details FLACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,115
Closed -$42K – 405
2022
Q1 		$42K Hold
4,115
– – 0.01% 271
2021
Q4 		$41K Sell
4,115
-30,000
-88% -$300K 0.01% 283
2021
Q3 		$343K Hold
34,115
– – 0.06% 184
2021
Q2 		$343K Buy
34,115
+4,115
+14% +$41.7K 0.05% 195
2021
Q1 		$305K Hold
30,000
– – 0.04% 285
2020
Q4 		$312K Buy
+30,000
New +$313K 0.04% 231

Other funds holding FLACU

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Longfellow Investment Management's FLACU Position: Q2 2022 in Review

Longfellow Investment Management sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q2 2022, closing a stake of 4,115 shares — an estimated $42K sold.

Longfellow Investment Management first reported a position in FLACU in Q4 2020 and held it in 6 quarters. The position peaked at $343K in Q3 2021. 17 funds tracked by Wall St. Rank hold FLACU as of Q2 2022.

  • Longfellow Investment Management reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q2 2022 after selling out during the quarter.
  • Longfellow Investment Management sold 4,115 Frazier Lifesciences Acquisition Corporation Unit shares in Q2 2022, an estimated $42K.
  • Longfellow Investment Management first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 6 quarters.
  • Longfellow Investment Management's Frazier Lifesciences Acquisition Corporation Unit position peaked at $343K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q2 2022.

Based on Longfellow Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.